A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy

by lowes1 on October 8, 2013

Conditions:   Lung Cancer;   Tuberculosis;   Sarcoidosis;   Interstitial Lung Disease
Interventions:   Drug: 1% lignocaine;   Drug: 2% lignocaine
Sponsors:   Postgraduate Institute of Medical Education and Research;   Postgraduate Institute of Medical Education and Research
Not yet recruiting – verified September 2013

View full post on ClinicalTrials.gov: “Lung Neoplasms” | updated in the last 30 days

Leave a Comment

Previous post:

Next post: